feed,title,long_url,short_url
MX,"ACTIV-2d, a global phase 3 trial of novel investigational COVID-19 oral antiviral agent, launches",https://medicalxpress.com/news/2022-08-activ-2d-global-phase-trial-covid-.html,https://bit.ly/3dPDfys
MX,Hepatitis C drugs may reduce PTSD symptoms,https://medicalxpress.com/news/2022-08-hepatitis-drugs-ptsd-symptoms.html,https://bit.ly/3CoSlVH
MX,Those suffering from autoimmune diseases require a third coronavirus vaccination,https://medicalxpress.com/news/2022-08-autoimmune-diseases-require-coronavirus-vaccination.html,https://bit.ly/3dPDjOI
